New shot every 2 weeks could control tumor growth in gut cancers
NCT ID NCT05050942
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial compares a new form of octreotide (CAM2029) given as a shot every 2 weeks to standard monthly injections in 332 people with advanced neuroendocrine tumors of the gut or pancreas. The main goal is to see if the new drug delays tumor growth better than current treatments. Participants whose disease worsens may receive a higher dose of CAM2029 in an extension phase.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
octreotide (CAM2029)
What this could lead to
If it works, this could offer a more convenient treatment option for people with advanced neuroendocrine tumors, potentially slowing tumor growth.
What could go wrong
This is a phase 3 trial, but results are not yet available. The new drug may not be more effective than current treatments, and side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ASST degli Spedali Civili di Brescia
Brescia, Italy
-
AZ Nikolaas
Sint-Niklaas, Belgium
-
Algemeen Ziekenhuis Maria Middelares
Ghent, Belgium
-
Antwerp University Hospital
Edegem, Belgium
-
Azienda Ospedaliera Sant'Andrea
Roma, Italy
-
Azienda Ospedaliero - Universitaria di Bologna Policlinico S. Orsola - Malpighi
Bologna, Italy
-
Azienda Ospedaliero - Universitaria di Modena Policlinico
Modena, Italy
-
BC Cancer Agency Vancouver Centre
Vancouver, Canada
-
Bács-Kiskun Megyei Kórház
Kecskemét, Hungary
-
CHRU de Tours - Hopital Trousseau
Chambray-lès-Tours, France
-
CHU Hopitaux de Bordeaux - Hôpital Haut-Lévêque
Bordeaux, France
-
CHU de Lyon - Groupement Hospitalier Edouard Herriot
Lyon, France
-
CHU de Nantes - Hôtel-Dieu
Nantes, France
-
Centre Eugène Marquis
Rennes, France
-
Centre Hospitalier Universitaire Dijon Bourgogne - L'Hopital General
Dijon, France
-
Centre Hospitalier de l'Universite de Montreal - Notre-Dame Hospital
Montreal, Canada
-
Charite - UB - CVK - Medizinische Klinik
Berlin, Germany
-
Cliniques Universitaires Saint-Luc
Brussels, Belgium
-
Complexo Hospitalario Universitario A Coruña
A Coruña, Spain
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
East Jefferson General Hospital
Metairie, Louisiana, 70065, United States
-
Erasmus MC
Rotterdam, Netherlands
-
Facultad de Medicina - Hospital Universitario Fundacion Jimenez Diaz (UAM-FJD) (Clinica de la Concepcion)
Madrid, Spain
-
Fiona Stanley Hospital
Murdoch, Australia
-
GenesisCare - North Shore
Alexandria, Australia
-
Groupe Hospitalier de l'Institut Catholique de Lille - Hopital Saint Vincent de Paul
Lille, France
-
Hadassah Medical Center (HMC) - Hadassah University Hospital (HUH) - Ein Kerem
Jerusalem, Israel
-
Hospital General Universitario Morales Meseguer
Murcia, Spain
-
Hospital General Universitario de Elche
Elche, Spain
-
Hospital Universitari Vall d'Hebron - Vall d'Hebron Institut d'Oncologia (VHIO)
Barcelona, Spain
-
Hospital Universitari de Girona Doctor Josep Trueta
Girona, Spain
-
Hospital Universitario Central de Asturias
Oviedo, Spain
-
Hospital Universitario Fundación Alcorcón
Madrid, Spain
-
Hospital Universitario La Paz (HULP)
Madrid, Spain
-
Hospital Universitario Marques de Valdecilla (HUMV)
Santander, Spain
-
Hospital Universitario Ramón y Cajal
Madrid, Spain
-
Hospital Universitario Virgen de la Victoria
Málaga, Spain
-
Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
-
Hôpital Erasme
Brussels, Belgium
-
Hôpitaux Universitaires de Strasbourg - Hôpital de Hautepierre
Strasbourg, France
-
IRCCS - Istituto Nazionale dei Tumori di Napoli Fondazione G. Pascale - Oncologia Addominale
Naples, Italy
-
Institut Catala d'Oncologia Hospitalet
Barcelona, Spain
-
Institutul Clinic Fundeni
Bucharest, Romania
-
Institutul Oncologic "Prof. Dr. Ion Chiricuţă" Cluj Napoca
Cluj-Napoca, Romania
-
Istituto Clinico Humanitas
Milan, Italy
-
Istituto Oncologico Veneto - IRCCS
Padova, Italy
-
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST IRCCS
Meldola, Italy
-
Jewish General Hospital
Montreal, Canada
-
London Health Sciences Centre
London, Canada
-
MD Anderson Cancer Center - Madrid
Madrid, Spain
-
Maastricht UMC+
Maastricht, Netherlands
-
Mayo Clinic Cancer Center (MCCC) - Phoenix
Phoenix, Arizona, 85054, United States
-
Mayo Clinic Hospital - Florida
Jacksonville, Florida, 32224, United States
-
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
-
Medisprof SRL
Cluj-Napoca, Romania
-
Medizinischen Fakultät Mannheim der Universität Heidelberg
Mannheim, Germany
-
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065, United States
-
Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
Heidelberg, Germany
-
Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
Amsterdam, Netherlands
-
Niagara Health System - St. Catharines General Site
St. Catharines, Canada
-
Parc Taulí Sabadell Hospital Universitari
Sabadell, Spain
-
Petz Aladár Megyei Oktató Kórház
Győr, Hungary
-
Princess Margaret Cancer Centre
Toronto, Canada
-
Rambam Medical Center
Haifa, Israel
-
Rijnstate Ziekenhuis - Arnhem
Arnhem, Netherlands
-
Rocky Mountain Cancer Centers - Denver - Midtown
Denver, Colorado, 80218, United States
-
SE ÁOK I. sz. Belgyógyászati Klinika
Budapest, Hungary
-
Sigmedical Services S.R.L.
Suceava, Romania
-
Sunnybrook Health Sciences Centre
Toronto, Canada
-
Szegedi Tudományegyetem; I.Belgyógyászati Klinika
Szeged, Hungary
-
Texas Oncology - Austin
Austin, Texas, 78705, United States
-
Texas Oncology - Dallas
Dallas, Texas, 75246, United States
-
Texas Oncology - McAllen
McAllen, Texas, 78503, United States
-
Texas Oncology - San Antonio Northeast
San Antonio, Texas, 78240, United States
-
The Chaim Sheba Medical Center
Ramat Gan, Israel
-
The Ottawa Hospital - General Campus
Ottawa, Canada
-
The University of Texas - MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
UCLA Ahmanson Biological Imaging Center
Santa Monica, California, 90404, United States
-
Universita Degli Studi di Genova - Center of Excellence for Biomedical Research (CEBR)
Genova, Italy
-
Universita degli Studi di Bari - Aldo Moro
Bari, Italy
-
Universita degli Studi di Firenze - Azienda Ospedaliero - Universitaria Careggi - SC di Oncologia Medical
Florence, Italy
-
Universitaetsklinikum Erlangen - Hautklinik
Erlangen, Germany
-
University of Kentucky (UK) - Markey Cancer Center
Lexington, Kentucky, 40536, United States
-
Universitätsklinikum Essen
Essen, Germany
-
Universitätsklinikum Hamburg-Eppendorf (UKE)
Hamburg, Germany
-
Universitätsklinikum Ulm
Ulm, Germany